183 related articles for article (PubMed ID: 16964332)
1. Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers.
Messai Y; Benhassine T; Naim M; Paul G; Bakour R
Rev Esp Quimioter; 2006 Jun; 19(2):144-51. PubMed ID: 16964332
[TBL] [Abstract][Full Text] [Related]
2. [Identification and expression of blaCTX-M-14 and blaCTX-M-24].
Xiong ZZ; Zhu DM; Wang F; Zhang YY
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1454-9. PubMed ID: 15500745
[TBL] [Abstract][Full Text] [Related]
3. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
4. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
[TBL] [Abstract][Full Text] [Related]
6. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
7. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
10. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
11. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
She D; Liu Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
[TBL] [Abstract][Full Text] [Related]
12. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
[TBL] [Abstract][Full Text] [Related]
13. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
Wang WP; Shao HF; Wang JN; Zhang XW; Shi LN
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals.
Iabadene H; Messai Y; Ammari H; Alouache S; Verdet C; Bakour R; Arlet G
Int J Antimicrob Agents; 2009 Oct; 34(4):340-2. PubMed ID: 19570655
[TBL] [Abstract][Full Text] [Related]
15. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R
Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867
[TBL] [Abstract][Full Text] [Related]
17. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
[TBL] [Abstract][Full Text] [Related]
18. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.
Costa D; Vinué L; Poeta P; Coelho AC; Matos M; Sáenz Y; Somalo S; Zarazaga M; Rodrigues J; Torres C
Vet Microbiol; 2009 Sep; 138(3-4):339-44. PubMed ID: 19372011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
